Cargando…
O-GlcNAc modification blocks the aggregation and toxicity of the Parkinson’s disease associated protein α-synuclein
Several aggregation-prone proteins associated with neurodegenerative diseases can be modified by O-linked N-acetyl-glucosamine (O-GlcNAc) in vivo. One of these proteins, α-synuclein, is a toxic aggregating-protein associated with synucleinopathies, including Parkinson’s disease. However, the effect...
Autores principales: | Marotta, Nicholas P., Lin, Yu Hsuan, Lewis, Yuka E., Ambroso, Mark R., Zaro, Balyn W., Roth, Maxwell T., Arnold, Don B., Langen, Ralf, Pratt, Matthew R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618406/ https://www.ncbi.nlm.nih.gov/pubmed/26492012 http://dx.doi.org/10.1038/nchem.2361 |
Ejemplares similares
-
Changes
in Metabolic Chemical Reporter Structure Yield
a Selective Probe of O-GlcNAc Modification
por: Chuh, Kelly N., et al.
Publicado: (2014) -
Identification of O-GlcNAc Modification Targets in Mouse Retinal Pericytes: Implication of p53 in Pathogenesis of Diabetic Retinopathy
por: Gurel, Zafer, et al.
Publicado: (2014) -
Correction to “Changes
in Metabolic Chemical
Reporter Structure Yield a Selective Probe of O-GlcNAc
Modification”
por: Chuh, Kelly N., et al.
Publicado: (2023) -
Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases
por: Pratt, Matthew R., et al.
Publicado: (2023) -
O-GlcNAc modification forces the formation of an α-Synuclein amyloid-strain with notably diminished seeding activity and pathology
por: Balana, Aaron T., et al.
Publicado: (2023)